{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:04:49Z","timestamp":1787025889096,"version":"build-2736575974"},"reference-count":60,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2022,11,8]]},"abstract":"<jats:p>Background: Excessive oxidative stress may contribute to neurodegeneration by leading to protein aggregation and mitochondrial dysfunction. Uric acid (UA) is an important endogenous antioxidant that protects against oxidative stress, yet its exact role in neurodegeneration remains unclear. Objective: To explore the performance of serum UA in neurodegenerative disorders. Methods: A total of 839 controls and 840 patients, including Alzheimer\u2019s disease (AD), Parkinson\u2019s disease (PD), multiple system atrophy (MSA), progressive supranuclear palsy (PSP), frontotemporal dementia (FTD), dementia with Lewy bodies (DLB), motor neuron disease (MND), Creutzfeldt-Jakob disease (CJD), and mixed dementia (MixD) were enrolled. Fasting serum UA levels were measured in all participants and compared between patients and controls. Linear regression models were utilized to explore possible relationships of serum UA with cognition, disease duration, age, and age of onset. Results: Compared to controls (355.48\u200a\u00b1\u200a85.38\u200a\u03bcmol\/L), serum UA was significantly lower in AD (291.29\u200a\u00b1\u200a83.49\u200a\u03bcmol\/L, p\u200a&lt;\u200a0.001), PD (286.95\u200a\u00b1\u200a81.78\u200a\u03bcmol\/L, p\u200a&lt;\u200a0.001), PSP (313.32\u200a\u00b1\u200a88.19\u200a\u03bcmol\/L, p\u200a&lt;\u200a0.001), FTD (313.89\u200a\u00b1\u200a71.18\u200a\u03bcmol\/L, p\u200a=\u200a0.001), and DLB (279.23\u200a\u00b1\u200a65.51\u200a\u03bcmol\/L, p\u200a&lt;\u200a0.001), adjusting for confounding factors including age, gender, education, etc. In addition, serum UA was positively correlated with cognitive levels in all patients (Mini-Mental State Examination: r\u200a=\u200a0.136, p\u200a=\u200a0.001; and Montreal Cognitive Assessment Scale: r\u200a=\u200a0.108, p\u200a=\u200a0.009). Conclusion: Decreased levels of serum UA were correlated with AD, PD, PSP, FTD, and DLB, offering significant potential as a promisingly relevant, less-invasive marker of multiple neurodegenerative disorders.<\/jats:p>","DOI":"10.3233\/jad-220432","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T11:36:13Z","timestamp":1664278573000},"page":"761-773","source":"Crossref","is-referenced-by-count":19,"title":["Serum Uric Acid Levels in Neurodegenerative Disorders: A Cross-Sectional Study"],"prefix":"10.1177","volume":"90","author":[{"given":"Qiaolifan","family":"Aerqin","sequence":"first","affiliation":[{"name":"Department of Neurology and Institute of Neurology, Huashan Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Shanghai Medical College, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha-Sha","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Neurology, Changzhou Second People\u2019s Hospital, Nanjing Medical University, Changzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Ning","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Neurology and Institute of Neurology, Huashan Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Shanghai Medical College, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Huashan Hospital Hongqiao Branch, Shanghai Medical College, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Liang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurology and Institute of Neurology, Huashan Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Shanghai Medical College, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Nan","family":"Ou","sequence":"additional","affiliation":[{"name":"Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Yuan","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Neurology and Institute of Neurology, Huashan Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Shanghai Medical College, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Neurology and Institute of Neurology, Huashan Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Shanghai Medical College, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Fen","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurology and Institute of Neurology, Huashan Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Shanghai Medical College, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Tai","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Neurology and Institute of Neurology, Huashan Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Shanghai Medical College, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-220432_ref1","doi-asserted-by":"crossref","first-page":"a028035","DOI":"10.1101\/cshperspect.a028035","article-title":"Pathology of neurodegenerative diseases","volume":"9","author":"Dugger","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.3233\/JAD-220432_ref2","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1007\/s12035-015-9337-5","article-title":"Oxidative stress in neurodegenerative diseases","volume":"53","author":"Niedzielska","year":"2016","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-220432_ref3","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.3233\/JAD-2010-1330","article-title":"Uric acid as a CNS antioxidant","volume":"19","author":"Bowman","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220432_ref4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5049\/EBP.2014.12.1.1","article-title":"Uric acid puzzle: Dual role as anti-oxidantand pro-oxidant","volume":"12","author":"Kang","year":"2014","journal-title":"Electrolyte Blood Press"},{"key":"10.3233\/JAD-220432_ref5","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/mds.26466","article-title":"Low serum uric acid levels in progressive supranuclear palsy","volume":"31","author":"Oropesa-Ruiz","year":"2016","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-220432_ref6","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1007\/s00415-013-7006-z","article-title":"Uric acid is associated with the prevalence but not disease progression of multiple system atrophy in Chinese population","volume":"260","author":"Cao","year":"2013","journal-title":"J Neurol"},{"key":"10.3233\/JAD-220432_ref7","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0361-9230(94)90285-2","article-title":"Uric acid is reduced in the substantia nigra in Parkinson\u2019s disease: Effect on dopamine oxidation","volume":"33","author":"Church","year":"1994","journal-title":"Brain Res Bull"},{"key":"10.3233\/JAD-220432_ref8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000346370","article-title":"Postmortem brain levels of urate and precursors in Parkinson\u2019s disease and related disorders","volume":"12","author":"McFarland","year":"2013","journal-title":"Neurodegener Dis"},{"key":"10.3233\/JAD-220432_ref9","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1002\/mds.22139","article-title":"Uric acid in Parkinson\u2019s disease","volume":"23","author":"Schlesinger","year":"2008","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-220432_ref10","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3389\/fneur.2020.00815","article-title":"A study of the relationship between uric acid and substantia nigra brain connectivity in patients with REM sleep behavior disorder and Parkinson\u2019s disease","volume":"11","author":"Ellmore","year":"2020","journal-title":"Front Neurol"},{"key":"10.3233\/JAD-220432_ref11","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3390\/nu10080975","article-title":"Uric acid and cognitive function in older individuals","volume":"10","author":"Tana","year":"2018","journal-title":"Nutrients"},{"key":"10.3233\/JAD-220432_ref12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11357-016-9871-8","article-title":"Serum uric acid level and association with cognitive impairment and dementia: Systematic review and meta-analysis","volume":"38","author":"Khan","year":"2016","journal-title":"Age (Dordr)"},{"key":"10.3233\/JAD-220432_ref13","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00702-017-1743-6","article-title":"Assessment of serum uric acid as risk factor for tauopathies","volume":"124","author":"Schirinzi","year":"2017","journal-title":"J Neural Transm (Vienna)"},{"issue":"Pt 2","key":"10.3233\/JAD-220432_ref14","first-page":"377","article-title":"Serum uric acid and cognitive function and dementia","volume":"132","author":"Euser","year":"2009","journal-title":"Brain"},{"key":"10.3233\/JAD-220432_ref15","doi-asserted-by":"crossref","first-page":"e94084","DOI":"10.1371\/journal.pone.0094084","article-title":"Serum uric acid levels in patients with Alzheimer\u2019s disease: A meta-analysis","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"10.3233\/JAD-220432_ref16","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/mds.26535","article-title":"Relationship between uric acid levels and progressive supranuclear palsy","volume":"31","author":"Brody","year":"2016","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-220432_ref17","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00415-010-5735-9","article-title":"An exploratory study of serum urate levels in patients with amyotrophic lateral sclerosis","volume":"258","author":"Zoccolella","year":"2011","journal-title":"J Neurol"},{"key":"10.3233\/JAD-220432_ref18","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1111\/ane.12012","article-title":"Serum and cerebrospinal fluid urate levels in synucleinopathies versus tauopathies","volume":"127","author":"Constantinescu","year":"2013","journal-title":"Acta Neurol Scand"},{"key":"10.3233\/JAD-220432_ref19","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/alz.12117","article-title":"Sleep characteristics and cerebrospinal fluid biomarkers of Alzheimer\u2019s disease pathology in cognitively intact older adults: The CABLE study","volume":"16","author":"Xu","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220432_ref20","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220432_ref21","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-220432_ref22","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"key":"10.3233\/JAD-220432_ref23","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: The Movement Disorder Society criteria","volume":"32","author":"Hoglinger","year":"2017","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-220432_ref24","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/brain\/awr179","article-title":"Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia","volume":"134","author":"Rascovsky","year":"2011","journal-title":"Brain"},{"key":"10.3233\/JAD-220432_ref25","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","article-title":"Classification of primary progressive aphasia and its variants","volume":"76","author":"Gorno-Tempini","year":"2011","journal-title":"Neurology"},{"key":"10.3233\/JAD-220432_ref26","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"10.3233\/JAD-220432_ref27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/146608200300079536","article-title":"El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"10.3233\/JAD-220432_ref29","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer\u2019s disease: The IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-220432_ref30","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0404.2010.01484.x","article-title":"Cognitive impairment using education-based cutoff points for CMMSE scores in elderly Chinese people of agricultural and rural Shanghai China","volume":"124","author":"Cui","year":"2011","journal-title":"Acta Neurol Scand"},{"key":"10.3233\/JAD-220432_ref31","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI42344","article-title":"Uric acid transport and disease","volume":"120","author":"So","year":"2010","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-220432_ref32","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/jcp.25509","article-title":"Uric acid amplifies abeta amyloid effects involved in the cognitive dysfunction\/dementia: Evidences from an experimental model in vitro","volume":"232","author":"Desideri","year":"2017","journal-title":"J Cell Physiol"},{"key":"10.3233\/JAD-220432_ref33","doi-asserted-by":"crossref","first-page":"12144","DOI":"10.1038\/srep12144","article-title":"Uric acid produces an inflammatory response through activation of NF-kappaB in the hypothalamus: Implications for the pathogenesis of metabolic disorders","volume":"5","author":"Lu","year":"2015","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-220432_ref34","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/mds.870100507","article-title":"No evidence for systemic oxidant stress in Parkinson\u2019s or Alzheimer\u2019s disease","volume":"10","author":"Ahlskog","year":"1995","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-220432_ref35","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.parkreldis.2011.01.013","article-title":"Uric acid and cognition in Parkinson\u2019s disease: A follow-up study","volume":"17","author":"Annanmaki","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JAD-220432_ref36","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jalz.2019.01.014","article-title":"Urate and risk of Alzheimer\u2019s disease and vascular dementia: A population-based study","volume":"15","author":"Scheepers","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220432_ref37","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.parkreldis.2018.05.010","article-title":"Serum uric acid level and its association with motor subtypes and non-motor symptoms in early Parkinson\u2019s disease: PALS study","volume":"55","author":"Huang","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JAD-220432_ref38","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s40520-020-01541-z","article-title":"Uric acid and late-onset Alzheimer\u2019s disease: Results from the ReGAl 2.0 project","volume":"33","author":"Boccardi","year":"2021","journal-title":"Aging Clin Exp Res"},{"key":"10.3233\/JAD-220432_ref39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1017\/S0317167100012981","article-title":"Serum urate and the risk of Parkinson\u2019s disease: Results from a meta-analysis","volume":"40","author":"Shen","year":"2013","journal-title":"Can J Neurol Sci"},{"key":"10.3233\/JAD-220432_ref40","doi-asserted-by":"crossref","first-page":"101152","DOI":"10.1016\/j.arr.2020.101152","article-title":"Shared perturbations in the metallome and metabolome of Alzheimer\u2019s, Parkinson\u2019s, Huntington\u2019s, and dementia with Lewy bodies: A systematic review","volume":"63","author":"Scholefield","year":"2020","journal-title":"Ageing Res Rev"},{"key":"10.3233\/JAD-220432_ref41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12883-018-1136-y","article-title":"Hyperuricemia and dementia - a case-control study","volume":"18","author":"Engel","year":"2018","journal-title":"BMC Neurol"},{"key":"10.3233\/JAD-220432_ref42","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/annrheumdis-2016-210767","article-title":"Uric acid and incident dementia over 12 years of follow-up: A population-based cohort study","volume":"77","author":"Latourte","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.3233\/JAD-220432_ref43","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3233\/JAD-201192","article-title":"Serum uric acid may aggravate Alzheimer\u2019s disease risk by affecting amyloidosis in cognitively intact older adults: The CABLE Study","volume":"81","author":"Li","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220432_ref44","doi-asserted-by":"crossref","first-page":"167 e111","DOI":"10.1016\/j.neurobiolaging.2020.02.018","article-title":"Impact of modifiable risk factors on Alzheimer\u2019s disease: A two-sample Mendelian randomization study","volume":"91","author":"Wang","year":"2020","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-220432_ref45","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/21678421.2017.1418005","article-title":"Pre-diagnostic plasma urate and the risk of amyotrophic lateral sclerosis","volume":"19","author":"O\u2019Reilly","year":"2018","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.3233\/JAD-220432_ref46","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/s41598-018-19609-2","article-title":"Serum uric acid levels in patients with amyotrophic lateral sclerosis: A meta-analysis","volume":"8","author":"Zhang","year":"2018","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-220432_ref47","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1179\/135100005X70242","article-title":"Biotransformation of nitric oxide in the cerebrospinal fluid of amyotrophic lateral sclerosis patients","volume":"10","author":"Kokic","year":"2005","journal-title":"Redox Rep"},{"key":"10.3233\/JAD-220432_ref48","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.clinbiochem.2015.09.017","article-title":"Serum uric acid and lipid profiles in sporadic Creutzfeldt-Jakob disease","volume":"49","author":"Chen","year":"2016","journal-title":"Clin Biochem"},{"key":"10.3233\/JAD-220432_ref49","doi-asserted-by":"crossref","first-page":"e00598","DOI":"10.1002\/brb3.598","article-title":"Serum uric acid levels in Parkinson\u2019s disease and related disorders","volume":"7","author":"Sakuta","year":"2017","journal-title":"Brain Behav"},{"key":"10.3233\/JAD-220432_ref50","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/mds.26466","article-title":"Low serum uric acid levels in progressive supranuclear palsy","volume":"31","author":"Oropesa-Ruiz","year":"2016","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-220432_ref51","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/mds.10486","article-title":"Nigral glutathione deficiency is not specific for idiopathic Parkinson\u2019s disease","volume":"18","author":"Fitzmaurice","year":"2003","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-220432_ref52","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fnagi.2020.00160","article-title":"Serum uric acid, Alzheimer-related brain changes, and cognitive impairment","volume":"12","author":"Kim","year":"2020","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-220432_ref53","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1212\/WNL.0000000000002351","article-title":"Prospective study of plasma urate and risk of Parkinson disease in men and women","volume":"86","author":"Gao","year":"2016","journal-title":"Neurology"},{"key":"10.3233\/JAD-220432_ref54","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3233\/JAD-150528","article-title":"Nutritional status is associated with faster cognitive decline and worse functional impairment in the progression of dementia: The Cache County Dementia Progression Study","volume":"52","author":"Sanders","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220432_ref55","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.exger.2012.05.008","article-title":"Association of serum uric acid with body mass index among long-lived Chinese","volume":"47","author":"Yue","year":"2012","journal-title":"Exp Gerontol"},{"key":"10.3233\/JAD-220432_ref56","doi-asserted-by":"crossref","first-page":"e39321","DOI":"10.1371\/journal.pone.0039321","article-title":"Serum uric acid and adiposity: Deciphering causality using a bidirectional Mendelian randomization approach","volume":"7","author":"Lyngdoh","year":"2012","journal-title":"PLoS One"},{"key":"10.3233\/JAD-220432_ref57","doi-asserted-by":"crossref","first-page":"27138","DOI":"10.1074\/jbc.M113.485094","article-title":"Uric acid secretion from adipose tissue and its increase in obesity","volume":"288","author":"Tsushima","year":"2013","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-220432_ref58","doi-asserted-by":"crossref","first-page":"dgaa638","DOI":"10.1210\/clinem\/dgaa638","article-title":"Associations of BMI and serum urate with developing dementia: A prospective cohort study","volume":"105","author":"Cao","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.3233\/JAD-220432_ref59","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/ene.12969","article-title":"Does serum uric acid act as a modulator of cerebrospinal fluid Alzheimer\u2019s disease biomarker related cognitive decline?","volume":"23","author":"Ye","year":"2016","journal-title":"Eur J Neurol"},{"key":"10.3233\/JAD-220432_ref60","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1523\/JNEUROSCI.18-02-00687.1998","article-title":"Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: Suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction","volume":"18","author":"Keller","year":"1998","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-220432_ref61","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/sj.mp.4001240","article-title":"Tyrosine nitration of a synaptic protein synaptophysin contributes to amyloid beta-peptide-induced cholinergic dysfunction","volume":"8","author":"Tran","year":"2003","journal-title":"Mol Psychiatry"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-220432","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:07:36Z","timestamp":1777370856000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-220432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,8]]},"references-count":60,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-220432","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,8]]}}}